Learn about a clinical trial at LSU Health Shreveport that could improve heart function in women with peripartum ...

Backed by positive data from the SCOUT-HCM trial, the FDA has granted Priority Review to mavacamten (Camzyos) for adolescent oHCM.

The new application was based on results from the Phase III SCOUT-HCM trial.

Cardiomyopathy can be a diverse diagnosis. There are many different types -- some inherited, others due to injury to the heart, treatment side effects, pregnancy, and a range of other causes. The ...

Folks who regularly exercise can lower their risk of heart attack and heart failure linked to a genetic heart condition, a ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...

From next-generation medications to groundbreaking gene therapies and nonsurgical procedures, explore the pipeline of treatments currently being tested for oHCM.

For cardiomyopathy that has progressed to heart failure, keeping a close eye on your condition and in close contact with your care team about any changes may help keep you stable and out of the ...

The human heart is a muscle, but it’s also a kind of complicated balloon—a balloon that fills and empties roughly 60 to 100 times every minute, and several billion times during the course of a ...